Coordination of altered DNA repair and damage pathways in arsenite-exposed keratinocytes.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 12377979)

Published in Toxicol Sci on October 01, 2002

Authors

Hisham K Hamadeh1, Kevin J Trouba, Rupesh P Amin, Cynthia A Afshari, Dori Germolec

Author Affiliations

1: Intramural Microarray Center, Laboratory of Molecular Toxicology, National Institute of Environmental Health Sciences/NIH, Research Triangle Park, NC 27709, USA.

Articles citing this

Integrating phenotypic and expression profiles to map arsenic-response networks. Genome Biol (2004) 1.90

Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1-Cul3 interaction. Toxicol Appl Pharmacol (2008) 1.39

Enhanced ROS production and redox signaling with combined arsenite and UVA exposure: contribution of NADPH oxidase. Free Radic Biol Med (2009) 1.05

Poly(ADP-ribose) polymerase-1 inhibition by arsenite promotes the survival of cells with unrepaired DNA lesions induced by UV exposure. Toxicol Sci (2012) 0.97

The effects of arsenic trioxide on DNA synthesis and genotoxicity in human colon cancer cells. Int J Environ Res Public Health (2010) 0.93

Distinct gene expression profiles in immortalized human urothelial cells exposed to inorganic arsenite and its methylated trivalent metabolites. Environ Health Perspect (2006) 0.92

Impact of trivalent arsenicals on selenoprotein synthesis. Environ Health Perspect (2006) 0.91

Global gene expression changes in human urothelial cells exposed to low-level monomethylarsonous acid. Toxicology (2011) 0.84

Arsenic biotransformation as a cancer promoting factor by inducing DNA damage and disruption of repair mechanisms. Mol Biol Int (2011) 0.84

A dose-response study of arsenic exposure and markers of oxidative damage in Bangladesh. J Occup Environ Med (2014) 0.82

Proteomic analysis of low dose arsenic and ionizing radiation exposure on keratinocytes. Proteomics (2009) 0.81

Knowledge building insights on biomarkers of arsenic toxicity to keratinocytes and melanocytes. Biomark Insights (2012) 0.80

Enhanced glutathione biosynthetic capacity promotes resistance to As3+-induced apoptosis. Toxicol Lett (2009) 0.79

Cytotoxicity patterns of arsenic trioxide exposure on HaCaT keratinocytes. Clin Cosmet Investig Dermatol (2011) 0.78

Human AP endonuclease 1: a potential marker for the prediction of environmental carcinogenesis risk. Oxid Med Cell Longev (2014) 0.78

Aberrantly Expressed Genes in HaCaT Keratinocytes Chronically Exposed to Arsenic Trioxide. Biomark Insights (2011) 0.78

Induction of cyclin D1 by arsenite and UVB-irradiation in human keratinocytes. J Health Care Poor Underserved (2011) 0.76

Transcriptional profiling of the age-related response to genotoxic stress points to differential DNA damage response with age. Mech Ageing Dev (2009) 0.76

Expression Of Selected Pathway-Marker Genes In Human Urothelial Cells Exposed Chronically To A Non-Cytotoxic Concentration Of Monomethylarsonous Acid. Toxicol Rep (2014) 0.75

Low dose arsenite confers resistance to UV induced apoptosis via p53-MDM2 pathway in ketatinocytes. Oncogenesis (2017) 0.75

Articles by these authors

Gene expression analysis reveals chemical-specific profiles. Toxicol Sci (2002) 2.50

Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol Pharmacol (2002) 2.49

Gene selection and clustering for time-course and dose-response microarray experiments using order-restricted inference. Bioinformatics (2003) 2.21

Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen. Mol Endocrinol (2003) 2.12

Integrating phenotypic and expression profiles to map arsenic-response networks. Genome Biol (2004) 1.90

Identification of putative gene based markers of renal toxicity. Environ Health Perspect (2004) 1.85

Prediction of compound signature using high density gene expression profiling. Toxicol Sci (2002) 1.82

Methapyrilene toxicity: anchorage of pathologic observations to gene expression alterations. Toxicol Pathol (2002) 1.72

Mot1 activates and represses transcription by direct, ATPase-dependent mechanisms. Proc Natl Acad Sci U S A (2002) 1.72

Use of a mixed tissue RNA design for performance assessments on multiple microarray formats. Nucleic Acids Res (2005) 1.70

Regulation of DNA replication fork genes by 17beta-estradiol. Mol Endocrinol (2002) 1.70

Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program. Cancer Cell (2004) 1.66

Immunological identification of the heart myoglobin radical formed by hydrogen peroxide. Free Radic Biol Med (2002) 1.52

Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells. Mol Cancer Res (2003) 1.48

Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repression. Mol Biol Cell (2002) 1.36

Identification of platform-independent gene expression markers of cisplatin nephrotoxicity. Environ Health Perspect (2004) 1.30

Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol Sci (2010) 1.22

Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkers. Toxicol Pathol (2005) 1.15

Overview on the application of transcription profiling using selected nephrotoxicants for toxicology assessment. Environ Health Perspect (2004) 1.14

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicol Sci (2013) 1.11

Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression. Gynecol Oncol (2002) 1.06

Oxidative stress and its role in skin disease. Antioxid Redox Signal (2002) 1.06

Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition. Proc Natl Acad Sci U S A (2004) 1.06

Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Ha-ras transgenic (Tg.AC) mice. Environ Health Perspect (2004) 1.06

ATM-dependent and -independent gene expression changes in response to oxidative stress, gamma irradiation, and UV irradiation. Radiat Res (2003) 1.04

Computational selection of distinct class- and subclass-specific gene expression signatures. J Biomed Inform (2002) 0.99

Arsenic-induced alterations in the contact hypersensitivity response in Balb/c mice. Toxicol Appl Pharmacol (2004) 0.98

An overview of toxicogenomics. Curr Issues Mol Biol (2002) 0.97

Differential toxicogenomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin in malignant and nonmalignant human airway epithelial cells. Toxicol Sci (2002) 0.97

Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis. J Biol Chem (2003) 0.97

Integration of clinical and gene expression endpoints to explore furan-mediated hepatotoxicity. Mutat Res (2004) 0.97

Evaluation of a lymph node proliferation assay for its ability to detect pharmaceuticals with potential to cause immune-mediated drug reactions. J Immunotoxicol (2005) 0.97

CTNNA3 (α-catenin) gene variants are associated with diisocyanate asthma: a replication study in a Caucasian worker population. Toxicol Sci (2012) 0.93

Novel consensus DNA-binding sequence for BRCA1 protein complexes. Mol Carcinog (2003) 0.92

Genomic interrogation of mechanism(s) underlying cellular responses to toxicants. Toxicology (2002) 0.92

Gene expression alterations in immune system pathways in the thymus after exposure to immunosuppressive chemicals. Environ Health Perspect (2010) 0.90

Synergistic effect of influenza a virus on endotoxin-induced mortality in rat pups: a potential model for sudden infant death syndrome. Pediatr Res (2002) 0.90

Identification of distinct and common gene expression changes after oxidative stress and gamma and ultraviolet radiation. Mol Carcinog (2003) 0.87

Alterations in apoptotic signaling in human idiopathic cardiomyopathic hearts in failure. Am J Physiol Heart Circ Physiol (2002) 0.86

Relative potency for altered humoral immunity induced by polybrominated and polychlorinated dioxins/furans in female B6C3F1/N mice. Toxicol Sci (2014) 0.86

Insight into redox-regulated gene networks in vascular cells. Bioinformation (2007) 0.83

Forum Series: the "Vision" for Toxicity Testing in the 21st Century: promises and conundrums. Toxicol Sci (2008) 0.82

Exploration of low-dose estrogen effects: identification of No Observed Transcriptional Effect Level (NOTEL). Toxicol Pathol (2004) 0.82

Alteration in regulation of inflammatory response to influenza a virus and endotoxin in suckling rat pups: a potential relationship to sudden infant death syndrome. FEMS Immunol Med Microbiol (2004) 0.81

Review article toxic oil syndrome: review of immune aspects of the disease. J Immunotoxicol (2005) 0.80

Application of genomics for identification of systemic toxicity triggers associated with VEGF-R inhibitors. Chem Res Toxicol (2010) 0.79

Whole-body inhalation exposure to 1-bromopropane suppresses the IgM response to sheep red blood cells in female B6C3F1 mice and Fisher 344/N rats. Inhal Toxicol (2010) 0.79

A novel statistical algorithm for gene expression analysis helps differentiate pregnane X receptor-dependent and independent mechanisms of toxicity. PLoS One (2010) 0.78

Induction of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin following endotoxin exposure. Toxicol Appl Pharmacol (2003) 0.77

Comparison of tissue dosimetry in the mouse following chronic exposure to arsenic compounds. J Toxicol Environ Health A (2005) 0.76

Genetic Basis of Irritant Susceptibility in Health Care Workers. J Occup Environ Med (2016) 0.75

Lack of evidence for contact sensitization by Pfiesteria extract. Environ Health Perspect (2007) 0.75